Medical exposure rapidly restructures gut microbiomes in remote Amazonian Indigenous communities
By
Maria G. Dominguez-Bello1,12,13,14 Send email to [email protected]
Sesame, salt, and substance. A flagship bake.
Summary
This study examines microbiome changes in remote Amazonian Indigenous communities (335 Amerindians across multiple villages) during the introduction of a sustained medical program, before major dietary or lifestyle transitions. The research shows that low-exposure villages have higher baseline gut microbiota diversity than medium-exposure villages. Key findings include rapid, site-specific microbiome restructuring, reduced diversity, and shifts in microbial networks and functions toward urban-associated profiles, with children exhibiting greater sensitivity to these changes.
Key quotes
· 3 pulledLow-exposure villages show higher baseline gut microbiota diversity than the medium-exposure villages.
Children exhibit greater sensitivity to these changes.
Rapid, site-specific restructuring, reduced diversity, and shifts in microbial networks and functions toward urban-associated profiles.
You might also wanna read

Microbial metabolite restores liver health by targeting PPARα and lipid metabolism through the gut-liver axis
This scientific research article reports on the therapeutic potential of a microbial metabolite (10-hydroxy-10-hydr) in alleviating liver in
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
